Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130.

Gp130 is a shared cell-surface signaling receptor for at least ten different hematopoietic cytokines, but the basis of its degenerate recognition properties is unknown. We have determined the crystal structure of human leukemia inhibitory factor (LIF) bound to the cytokine binding region (CHR) of gp130 at 2.5 A resolution. Strikingly, we find that the shared binding site on gp130 has an entirely rigid core, while the LIF binding interface diverges sharply in structure and chemistry from that of other gp130 ligands. Dissection of the LIF-gp130 interface, along with comparative studies of other gp130 cytokines, reveal that gp130 has evolved a "thermodynamic plasticity" that is relatively insensitive to ligand structure, to enable crossreactivity. These observations reveal a novel and alternative mechanism for degenerate recognition from that of structural plasticity.

[1]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[2]  P. Heinrich,et al.  Importance of the Membrane-Proximal Extracellular Domains for Activation of the Signal Transducer Glycoprotein 1301 , 2000, The Journal of Immunology.

[3]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[4]  J. Moreau,et al.  Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells , 1988, Nature.

[5]  L R Pease,et al.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.

[6]  G. Fantuzzi,et al.  Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. , 1996, Blood.

[7]  J. Heath,et al.  Crystal structure of a cytokine‐binding region of gp130 , 1998, The EMBO journal.

[8]  R. Prinjha,et al.  Neurobiology: Inhibitor of neurite outgrowth in humans , 2000, Nature.

[9]  D. Stuart,et al.  The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding , 1994, Cell.

[10]  E. Morita,et al.  The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice , 2001, Archives of Dermatological Research.

[11]  T. Kishimoto,et al.  IL-6 Receptor , 1990 .

[12]  L. Jan,et al.  Signaling mechanisms , 2005, Current Opinion in Neurobiology.

[13]  A. Landay,et al.  Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART , 2001, AIDS.

[14]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[15]  P. Heinrich,et al.  Molecular Modeling-guided Mutagenesis of the Extracellular Part of gp130 Leads to the Identification of Contact Sites in the Interleukin-6 (IL-6)·IL-6 receptor·gp130 Complex* , 1997, The Journal of Biological Chemistry.

[16]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[17]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[18]  J. Bazan,et al.  Haemopoietic receptors and helical cytokines. , 1990, Immunology today.

[19]  Martin E. Schwab,et al.  Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 , 2000, Nature.

[20]  K. Garcia,et al.  Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex , 2001, Science.

[21]  Fumio Nakamura,et al.  Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein , 2000, Nature.

[22]  T. Hirano,et al.  Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.

[23]  J. Heath,et al.  Crystal structure and functional dissection of the cytostatic cytokine oncostatin M. , 2000, Structure.

[24]  R M Esnouf,et al.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.

[25]  R. Mariuzza,et al.  Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions. , 2000, Structure.

[26]  M. Schumacher,et al.  Structural Mechanisms of QacR Induction and Multidrug Recognition , 2001, Science.

[27]  T. Hirano,et al.  Signaling mechanisms through gp130: a model of the cytokine system. , 1997, Cytokine & growth factor reviews.

[28]  Enrico A. Stura,et al.  Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å , 1996, Science.

[29]  J. Zou.  Improved methods for building models in electron density maps and their application to carbohydrate-binding proteins , 1995 .

[30]  D. Hilton,et al.  Generation of sensory neurons is stimulated by leukemia inhibitory factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Heinrich,et al.  A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. , 2002, European journal of biochemistry.

[32]  D. Hilton,et al.  The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor* , 1998, The Journal of Biological Chemistry.

[33]  J. Heath,et al.  Characterization of the Receptor Binding Sites of Human Leukemia Inhibitory Factor and Creation of Antagonists (*) , 1996, The Journal of Biological Chemistry.

[34]  E A Merritt,et al.  Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.

[35]  R. Aebersold,et al.  The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. , 1989, Science.

[36]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[37]  L. D. Ward,et al.  Interleukin‐6: Structure‐function relationships , 1997, Protein science : a publication of the Protein Society.

[38]  S. Daburon,et al.  Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation* , 2002, The Journal of Biological Chemistry.

[39]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[40]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[41]  D. Ringe,et al.  Locating and characterizing binding sites on proteins , 1996, Nature Biotechnology.

[42]  K. Garcia,et al.  Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex , 2003, Science.

[43]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[44]  A. Wollmer,et al.  Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. , 1997, Blood.

[45]  S. Atwell,et al.  Structural plasticity in a remodeled protein-protein interface. , 1997, Science.

[46]  W. Delano,et al.  Convergent solutions to binding at a protein-protein interface. , 2000, Science.

[47]  D. Hilton,et al.  Purification of a murine leukemia inhibitory factor from Krebs ascites cells. , 1988, Analytical biochemistry.

[48]  D. Baker,et al.  A simple physical model for binding energy hot spots in protein–protein complexes , 2002, Proceedings of the National Academy of Sciences of the United States of America.